| Cardiovascular disease/dyslipidemia |
|
|
| Apo E Genotype Test (for type III hyperlipoproteinemia) |
| 1 day |
Celiac disease |
|
|
| Celiac Disease DNA Test |
| 1 day |
Celiac Disease Antibody Panel
tTG-IgA, EMA-IgA, Gliadin IgA and IgG, Total IgA
|
| 2-3 days |
| Endomysial (EMA) IgA Antibody |
| 2-3 days |
| Gliadin IgA Antibody |
| 2-3 days |
| Gliadin IgG Antibody |
| 2-3 days |
| Gliadin IgA and IgG Antibodies |
| 2-3 days |
| Reticulin IgA Antibody |
| 2-3 days |
| Reticulin Total Antibodies |
| 2-3 days |
| Tissue Transglutaminase (tTG) IgA Antibody |
| 2-3 days |
| Tissue Transglutaminase (tTG) IgG Antibody |
| 2-3 days |
| Tissue Transglutaminase (tTG) IgA and IgG Antibodies |
| 2-3 days |
| Total IgA |
| 2-3 days |
Cystic fibrosis |  |
|
| Cystic Fibrosis DNA Test – Carrier screening and diagnostic testing |
| 1 day |
| Cystic Fibrosis DNA Test – Prenatal testing |
| 3 days |
Fragile X syndrome and related testing |
|
|
| Fragile X DNA Test |
| 7-11 days |
| Fragile X Protein (FMRP) Test |
| 2-3 weeks |
| Fragile X DNA/Standard Chromosome Analysis Combined Test |
| 7-14 days |
| FRAXE DNA Test |
| 10-14 days |
| FXTAS DNA Test (Fragile X-Associated Tremor/Ataxia Syndrome) |
| 7-11 days |
Hemochromatosis |
|
|
| Hemochromatosis DNA Test |
| 1 day |
HLA-B27 (ankylosing spondylitis) |
|
|
| HLA-B27 DNA Test |
| 1 day |
Hypercoagulability |
|
|
| Factor V Leiden DNA Test |
| 1 day |
| Prothrombin (Factor II) DNA Test |
| 1 day |
| Factor V Leiden/Prothrombin (Factor II) Combined DNA Test |
| 1 day |
| Factor V R2 DNA Test |
| 1 day |
| MTHFR DNA Test |
| 1 day |
|
|
|
| Inherited Hypercoagulability Panel A (for patients not on Coumadin therapy)** |
| 2-3 days |
Factor V Leiden DNA Test, Prothrombin (Factor II) DNA Test, Antithrombin III Activity, Protein C Activity, Protein S Activity
|
|
|
|
|
|
| Inherited Hypercoagulability Panel B (for patients on Coumadin therapy)** |
| 4-6 days |
Factor V Leiden DNA Test, Prothrombin (Factor II) DNA Test, Antithrombin III Activity, Protein C/Factor IX Antigen Ratio, Protein S/Factor IX Antigen Ratio
|
|
|
|
|
|
| High Risk Pregnancy Hypercoagulability Panel** |
| 7 days |
Factor V Leiden DNA Test, Prothrombin (Factor II) DNA Test, Antithrombin III Activity, Protein C Activity, Protein S Activity, Antiphospholipid Antibody Syndrome Tests (Lupus Anticoagulant and Anticardiolipin Antibodies IgG, IgM, and IgA), Antinuclear Antibody Screen
|
|
|
|
|
|
| Anti-β2 Glycoprotein I Antibody Test (IgG, IgM, and IgA) |
| 3-5 days |
| Homocysteine (serum) |
| 5-6 days |
Narcolepsy |
|
|
| Narcolepsy DNA Test |
| 2 days |
Periodontal Disease |
|
|
| PST® Genetic Test for Susceptibility to Periodontal Disease |
| 1-2 days |
PST® is a registered service mark of Interleukin Genetics, Inc.
PST® genotyping is performed under a license from Interleukin Genetics, Inc. |
|
|
Pharmacogenetics |
|
|
| Warfarin DoseAdvise™ Genetic Test (CYP2C9 and VKORC1) |
| 1 day |
|
|
|
| Irinotecan DoseAdvise™ Genetic Test (UGT1A1) |
| 1 day |
Tay-Sachs disease |
|
|
| Tay-Sachs DNA Test |
| 1 day |
| Tay-Sachs Enzyme Test |
| 3-5 days |
